Cargando…

Use of mesenchymal stem cells for chronic kidney disease

Detalles Bibliográficos
Autor principal:	Chung, Byung Ha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Nephrology 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6577207/ https://www.ncbi.nlm.nih.gov/pubmed/31189218 http://dx.doi.org/10.23876/j.krcp.19.051

Ejemplares similares

Mesenchymal Stem Cell Therapy in Nonhematopoietic Diseases
por: de Carvalho, Katherine Athayde Teixeira, et al.
Publicado: (2015)

Biomarker for recurrent immunoglobulin A nephropathy in kidney allografts: promising but still a long way to go
por: Chung, Byung Ha
Publicado: (2021)

Mesenchymal stem cells in autoimmune diseases: hype or hope?
por: Scherer, Hans U, et al.
Publicado: (2010)

Hip Fracture in Chronic Kidney Disease Patients: Necessity of Multidisciplinary Approach
por: Yoon, Byung-Ho, et al.
Publicado: (2017)

Mesenchymal Stem/Stromal Cells in Immunity and Disease: A Better Understanding for an Improved Use
por: Merimi, Makram, et al.
Publicado: (2020)

Mesenchymal stem cells: A new therapeutic tool for chronic kidney disease
por: Wang, Jiali, et al.
Publicado: (2022)

Use of sofosbuvir in chronic kidney disease: Is it necessary?
por: Lim, Tae Seop, et al.
Publicado: (2017)

New Sources, Differentiation, and Therapeutic Uses of Mesenchymal Stem Cells
por: Park, Saeyoung, et al.
Publicado: (2021)

Stem Cell Applications in Regenerative Medicine for Kidney Diseases
por: Rangel, Érika B., et al.
Publicado: (2021)

Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease
por: Franco, Marcella Liciani, et al.
Publicado: (2021)

Clinical Perspectives of Mesenchymal Stem Cells
por: Kramer, Jan, et al.
Publicado: (2012)

Mesenchymal Stem Cells and Regenerative Medicine
por: Sumer, Huseyin, et al.
Publicado: (2018)

The Immunomodulatory Properties of Mesenchymal Stem Cells
por: Xu, Junji, et al.
Publicado: (2018)

Special Issue “The Role of Mesenchymal Stem Cells on Inflammatory and Fibrotic Diseases”
por: Di Vincenzo, Mariangela, et al.
Publicado: (2023)

Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease
por: Yun, Chul Won, et al.
Publicado: (2019)

Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to Rituximab and Intravenous Immunoglobulin
por: Ban, Tae Hyun, et al.
Publicado: (2021)

Pioglitazone Improves the Function of Human Mesenchymal Stem Cells in Chronic Kidney Disease Patients
por: Yoon, Yeo Min, et al.
Publicado: (2019)

Lysyl Oxidase at the Crossroads of Mesenchymal Stem Cells and Epithelial-Mesenchymal Transition
por: Thomas, Clémence, et al.
Publicado: (2013)

Advances in Chronic Kidney Disease
por: Parrish, Alan R.
Publicado: (2016)

Chronic Kidney Disease is on the Rise
por: Haileamlak, Abraham
Publicado: (2018)

The gut–kidney connection in advanced chronic kidney disease
por: Inagi, Reiko
Publicado: (2015)

Mesenchymal Stem Cells: Characteristics, Function, and Application
por: Li, Zhongjun, et al.
Publicado: (2019)

Adipose Tissue-Derived Mesenchymal Stem Cells
por: Bunnell, Bruce A.
Publicado: (2021)

The advantages and limitations of mesenchymal stem cells in clinical application for treating human diseases
por: Lee, Seoung Hoon
Publicado: (2018)

Mesenchymal Stem Cells—Potential Applications in Kidney Diseases
por: Bochon, Benjamin, et al.
Publicado: (2019)

New Sources, Differentiation, and Therapeutic Uses of Mesenchymal Stem Cells 2.0
por: Jung, Sung-Chul, et al.
Publicado: (2023)

Clinical Significance of the Interval Change of Plasma Neutrophil Gelatinase-Associated Lipocalin in Acute Kidney Injury and Acute Kidney Injury Superimposed on Chronic Kidney Disease
por: Kim, Ha Yeon, et al.
Publicado: (2019)

Metformin inhibits chronic kidney disease‐induced DNA damage and senescence of mesenchymal stem cells
por: Kim, Hyoungnae, et al.
Publicado: (2021)

Osteoblastogenesis of adipose-derived mesenchymal stem cells in chronic kidney disease patient with regular hemodialysis
por: Tjempakasari, Artaria, et al.
Publicado: (2022)

Mesenchymal Stem Cell-Derived Exosomes: Toward Cell-Free Therapeutic Strategies in Chronic Kidney Disease
por: Cao, Qinghua, et al.
Publicado: (2022)

Chronic Kidney Disease: The Silent Epidemy
por: Bellasi, Antonio, et al.
Publicado: (2019)

Diastolic dysfunction and chronic kidney disease
por: Cho, Goo-Yeong
Publicado: (2013)

Immunoregulation of Inflammation in Chronic Kidney Disease
por: Takase, Osamu, et al.
Publicado: (2014)

Chronic kidney disease and the aging population
por: Tonelli, M., et al.
Publicado: (2014)

Chronic Kidney Disease and the Aging Population
por: Tonelli, M., et al.
Publicado: (2014)

Chronic kidney disease in disadvantaged populations
por: Garcia-Garcia, G., et al.
Publicado: (2015)

Adipokines and their role in chronic kidney disease
por: Khazaei, Majid
Publicado: (2015)

Oxidative Stress in Chronic Kidney Disease
por: Scholze, Alexandra, et al.
Publicado: (2016)

Prime time for chronic kidney disease
por: Weisman, David S., et al.
Publicado: (2023)

Human Adipose Tissue Derived Mesenchymal Stem Cells Aggravate Chronic Cyclosporin Nephrotoxicity by the Induction of Oxidative Stress
por: Chung, Byung Ha, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gab0ia96lg78jpv68jvkemnau9